U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06865989) titled 'Omnipod(R) SmartAdjust 2.0 System Compared to the Omnipod(R) 5 System in Individuals With Type 1 Diabetes' on March 04.
Brief Summary: The goal of this multi-center, randomized, cross-over study is to evaluate the safety and effectiveness of the Omnipod 5 SmartAdjust 2.0 System in individuals with type 1 diabetes.
Study participants will complete about 5 in-person visits and be expected to treat their diabetes per their usual routine using the system at the lowest available target setting.
Each participant will begin the study using either the Omnipod 5 SmartAdjust 2.0 System or the Omnipod 5 System for 4 weeks (Period 1) then sw...